Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001808296-26-000002

Director acquired 7,142 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Farzan Nima Director 2026-06-03 Grant or award +7,142 12,392 D
Derivatives
Farzan Nima Director 2026-06-03 Grant or award · Stock Option (right to buy) +7,433 7,433 D
Loading xslF345X06/form4-06052026_040603.xml…